F Dx Advisors, Inc. Edwards Lifesciences Corp Transaction History

F Dx Advisors, Inc.

$362 Million
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$86.5 - $128.27 $314,168 - $465,876	3,632 New	3,632 $345,000
Q1 2022 May 03, 2022	SELL	$101.96 - $128.34 $213,402 - $268,615	-2,093 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$106.37 - $130.68 $721,507 - $886,402	-6,783 Reduced 76.42%	2,093 $271,000
Q3 2021 Oct 08, 2021	SELL	$102.91 - $122.75 $222,491 - $265,385	-2,162 Reduced 19.59%	8,876 $1.01 Million
Q2 2021 Aug 05, 2021	BUY	$83.84 - $104.76 $212,618 - $265,671	2,536 Added 29.83%	11,038 $1.14 Million
Q1 2021 Apr 14, 2021	BUY	$78.68 - $90.67 $612,995 - $706,409	7,791 Added 1095.78%	8,502 $711,000
Q1 2021 Apr 13, 2021	SELL	$78.68 - $90.67 $1.38 Million - $1.59 Million	-17,490 Reduced 96.09%	711 $59,000
Q1 2020 May 13, 2020	BUY	$52.41 - $81.0 $677,923 - $1.05 Million	12,935 Added 245.63%	18,201 $210,000
Q4 2019 Feb 12, 2020	SELL	$71.7 - $82.09 $24,378 - $27,910	-340 Reduced 6.06%	5,266 $1.23 Million
Q3 2019 Nov 07, 2019	BUY	$61.55 - $75.43 $49,732 - $60,947	808 Added 16.84%	5,606 $1.23 Million
Q2 2019 Jul 19, 2019	SELL	$55.74 - $64.41 $8,026 - $9,275	-144 Reduced 2.91%	4,798 $886,000
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $197,402 - $264,014	-4,122 Reduced 45.48%	4,942 $946,000
Q4 2018 Apr 29, 2019	SELL	$46.41 - $56.94 $361,348 - $443,334	-7,786 Reduced 46.21%	9,064 $1.39 Million
Q4 2018 Feb 07, 2019	BUY	$46.41 - $56.94 $366,128 - $449,199	7,889 Added 88.04%	16,850 $2.58 Million
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $35,280 - $44,799	772 Added 9.43%	8,961 $1.56 Million
Q2 2018 Aug 08, 2018	SELL	$42.45 - $51.3 $271,722 - $328,371	-6,401 Reduced 43.87%	8,189 $1.19 Million
Q1 2018 May 02, 2018	SELL	$37.19 - $47.45 $92,305 - $117,770	-2,482 Reduced 14.54%	14,590 $2.04 Million
Q4 2017 Feb 09, 2018	SELL	$33.79 - $39.39 $25,646 - $29,897	-759 Reduced 4.26%	17,072 $1.92 Million
Q3 2017 Nov 03, 2017	BUY	$36.29 - $38.83 $141,603 - $151,514	3,902 Added 28.01%	17,831 $1.95 Million
Q2 2017 Aug 11, 2017	BUY	N/A	13,929	13,929 $1.65 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account